Name	Ornidazole
Description	Ornidazole (Tiberal) is a nitroimidazole antiprotozoal agent used in ameba and trichomonas infections. It is partially plasma-bound and also has radiation-sensitizing action.
In vitro	Ornidazole is a 5-nitroimidazole derivative active against protozoa and anaerobic bacteria. It is converted to reduction products that interact with DNA to cause destruction of helical DNA structure and strand leading to a protein synthesis inhibition and cell death in susceptible organisms.
Storage	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
Solubility Information	H2O : 2 mg/mL (9.1 mM) Ethanol : 41 mg/mL (186.7 mM) DMSO : 55 mg/mL (250.42 mM), Sonication is recommended.
Keywords	Inhibitor \| Bacterial \| Antibiotic \| Parasite \| inhibit \| NSC95075 \| Ornidazole \| NSC-95075
Inhibitors Related	Neomycin sulfate \| Dehydroacetic acid sodium \| Ampicillin sodium \| Methyl anthranilate \| Kanamycin sulfate \| Sulfamethoxazole sodium \| Hydroxychloroquine \| Metronidazole \| Doxycycline \| EDTA copper(II) disodium salt \| Dimethyl sulfoxide \| Crystal Violet
Related Compound Libraries	FDA-Approved & Pharmacopeia Drug Library \| Anti-Parasitic Compound Library \| Bioactive Compound Library \| Drug Repurposing Compound Library \| Drug-Fragment Library \| Anti-Bacterial Compound Library \| NO PAINS Compound Library \| Orally Active Compound Library \| Clinical Compound Library \| Bioactive Compounds Library Max

Ornidazole NEW

Product Introduction